Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Limits on Medicare's Ability to Control Rising Spending on Cancer DrugsThe New England journal of medicine, 2009-02, Vol.360 (6), p.626-633 [Peer Reviewed Journal]Copyright © 2009 Massachusetts Medical Society. All rights reserved. ;2009 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMhpr0807774 ;PMID: 19176475 ;CODEN: NEJMAGFull text available |
2 |
Material Type: Article
|
![]() |
US drug importation plan hits snagThe Lancet (British edition), 2021-06, Vol.397 (10291), p.2240-2240 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01334-9 ;PMID: 34119053Full text available |
3 |
Material Type: Article
|
![]() |
Regulating Drug Prices while Increasing InnovationThe New England journal of medicine, 2021-11, Vol.385 (21), p.1921-1923 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2113764 ;PMID: 34767322Full text available |
4 |
Material Type: Article
|
![]() |
Which Drug Prices Should Medicare Negotiate? A “Too Little” or “Too Late” ApproachThe New England journal of medicine, 2019-11, Vol.381 (22), p.2084-2086 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1912736 ;PMID: 31774952Full text available |
5 |
Material Type: Article
|
![]() |
Importing Prescription Drugs from Canada — Legal and Practical Problems with the Trump Administration’s ProposalThe New England journal of medicine, 2020-05, Vol.382 (19), p.1777-1779 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2000464 ;PMID: 32374960Full text available |
6 |
Material Type: Article
|
![]() |
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug–Pricing BoardsThe Milbank quarterly, 2021-12, Vol.99 (4), p.1162-1197 [Peer Reviewed Journal]2021 Milbank Memorial Fund ;2021 Milbank Memorial Fund. ;ISSN: 0887-378X ;EISSN: 1468-0009 ;DOI: 10.1111/1468-0009.12533 ;PMID: 34375015Full text available |
7 |
Material Type: Article
|
![]() |
The affordability for patients of a new universal MDR-TB coverage model in ChinaThe international journal of tuberculosis and lung disease, 2016-05, Vol.20 (5), p.638-644 [Peer Reviewed Journal]ISSN: 1027-3719 ;EISSN: 1815-7920 ;DOI: 10.5588/ijtld.15.0413 ;PMID: 27084818Full text available |
8 |
Material Type: Article
|
![]() |
Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database studyBMC health services research, 2018-06, Vol.18 (1), p.429-429, Article 429 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-018-3255-y ;PMID: 29879966Full text available |
9 |
Material Type: Article
|
![]() |
Price-cap Regulation, Uncertainty and the Price Evolution of New PharmaceuticalsHealth economics, 2015-08, Vol.24 (8), p.966-977 [Peer Reviewed Journal]2014 The Authors. Published by John Wiley & Sons Ltd. ;2014 The Authors. Health Economics Published by John Wiley & Sons Ltd. ;Copyright Wiley Periodicals Inc. Aug 2015 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.3075 ;PMID: 24990225Full text available |
10 |
Material Type: Article
|
![]() |
Drug Launch Timing and International Reference PricingHealth economics, 2015-08, Vol.24 (8), p.978-989 [Peer Reviewed Journal]Copyright © 2014 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. Aug 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.3078 ;PMID: 25044582Full text available |
11 |
Material Type: Article
|
![]() |
Antiretroviral purchasing and prescription practices in Mexico: constraints, challenges and opportunitiesSalud pública de México, 2015-01, Vol.57 Suppl 2 (suppl 2), p.s171-s182 [Peer Reviewed Journal]This work is licensed under a Creative Commons Attribution 3.0 International License. ;ISSN: 0036-3634 ;EISSN: 1606-7916 ;DOI: 10.21149/spm.v57s2.7606 ;PMID: 26545133Full text available |
12 |
Material Type: Article
|
![]() |
Can a medical need clause help manage the growing costs of prescription drugs in the EU?Health economics, policy and law, 2016-04, Vol.11 (2), p.179-192 [Peer Reviewed Journal]Cambridge University Press 2015 ;ISSN: 1744-1331 ;EISSN: 1744-134X ;DOI: 10.1017/S1744133115000389 ;PMID: 26333920Full text available |
13 |
Material Type: Article
|
![]() |
Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?Applied health economics and health policy, 2016-10, Vol.14 (5), p.507-509 [Peer Reviewed Journal]Springer International Publishing Switzerland 2016 ;Copyright Springer Science & Business Media Oct 2016 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.1007/s40258-016-0247-0 ;PMID: 27262556Full text available |
14 |
Material Type: Article
|
![]() |
Germany moves to lower drug pricesCanadian Medical Association journal (CMAJ), 2011-02, Vol.183 (2), p.E77-E78 [Peer Reviewed Journal]COPYRIGHT 2011 Joule Inc. ;Copyright Canadian Medical Association Feb 8, 2011 ;1995-2011, Canadian Medical Association ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.109-3759 ;PMID: 21173063 ;CODEN: CMAJAXFull text available |
15 |
Material Type: Article
|
![]() |
Unsettling Drug Patent Settlements: A Framework for Presumptive IllegalityMichigan law review, 2009-10, Vol.108 (1), p.37-80Copyright Michigan Law Review Association Oct 2009 ;ISSN: 0026-2234 ;EISSN: 1939-8557 ;PMID: 20535881Full text available |
16 |
Material Type: Article
|
![]() |
Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering DrugsPharmacoEconomics, 2009-01, Vol.27 (5), p.435-438 [Peer Reviewed Journal]Adis Data Information BV 2009 ;Copyright Wolters Kluwer Health Adis International May 2009 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200927050-00010 ;PMID: 19586083Full text available |
17 |
Material Type: Article
|
![]() |
340B: MAJOR CHANGES MAY BE COMING TO THE FEDERAL DRUG DISCOUNT PROGRAM FOR LOW-INCOME AND VULNERABLE POPULATIONSPhysician leadership journal, 2015-11, Vol.2 (6), p.42-44 [Peer Reviewed Journal]COPYRIGHT 2015 American College of Physician Executives ;Copyright American Association for Physician Leadership Nov/Dec 2015 ;ISSN: 2374-4030 ;EISSN: 2689-274X ;PMID: 26685459Full text available |
18 |
Material Type: Article
|
![]() |
Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?Health Affairs, 2003-05, Vol.22 (3), p.16-30 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE May/Jun 2003 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.22.3.16 ;PMID: 12757268Full text available |
19 |
Material Type: Article
|
![]() |
Pharmaceutical High Profits: The Value of R&D, or Oligopolistic Rents?The American journal of economics and sociology, 2012-01, Vol.71 (1), p.1-36 [Peer Reviewed Journal]2012 The American Journal of Economics and Sociology, Inc. ;2012 American Journal of Economics and Sociology, Inc. ;Copyright Blackwell Publishing Ltd. Jan 2012 ;ISSN: 0002-9246 ;EISSN: 1536-7150 ;DOI: 10.1111/j.1536-7150.2011.00820.x ;PMID: 22319815 ;CODEN: AJESA3Full text available |
20 |
Material Type: Article
|
![]() |
UK parses merits of value-based drug pricingNature biotechnology, 2007-04, Vol.25 (4), p.369-370 [Peer Reviewed Journal]COPYRIGHT 2007 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2007 ;ISSN: 1087-0156 ;EISSN: 1546-1696 ;DOI: 10.1038/nbt0407-369 ;PMID: 17420730Full text available |